13 research outputs found

    NMDA receptor gene variations as modifiers in Huntington disease: A replication study

    No full text
    Several candidate modifier genes which, in addition to the pathogenic CAG repeat expansion, influence the age at onset (AO) in Huntington disease (HD) have already been described. The aim of this study was to replicate association of variations in the N-methyl D-aspartate receptor subtype genes GRIN2A and GRIN2B in the "REGISTRY" cohort from the European Huntington Disease Network (EHDN). The analyses did replicate the association reported between the GRIN2A rs2650427 variation and AO in the entire cohort. Yet, when subjects were stratified by AO subtypes, we found nominally significant evidence for an association of the GRIN2A rs1969060 variation and the GRIN2B rs1806201 variation. These findings further implicate the N-methyl D-aspartate receptor subtype genes as loci containing variation associated with AO in HD

    NMDA receptor gene variations as modifiers in Huntington disease: a replication study.

    No full text
    none12siSeveral candidate modifier genes which, in addition to the pathogenic CAG repeat expansion, influence the age at onset (AO) in Huntington disease (HD) have already been described. The aim of this study was to replicate association of variations in the N-methyl D-aspartate receptor subtype genes GRIN2A and GRIN2B in the "REGISTRY" cohort from the European Huntington Disease Network (EHDN). The analyses did replicate the association reported between the GRIN2A rs2650427 variation and AO in the entire cohort. Yet, when subjects were stratified by AO subtypes, we found nominally significant evidence for an association of the GRIN2A rs1969060 variation and the GRIN2B rs1806201 variation. These findings further implicate the N-methyl D-aspartate receptor subtype genes as loci containing variation associated with AO in HD.openC. Saft; J. T. Epplen; S. Wieczorek; G. B. Landwehrmeyer; R. A. C;J. G. de;M. Dose;S. J. Tabrizi;D. Craufurd;R. E. G.;Investigators of the European Huntington's Disease Network [E. Di Maria];L. ArningC., Saft; J. T., Epplen; S., Wieczorek; G. B., Landwehrmeyer; R. A., C; J. G., De; M., Dose; S. J., Tabrizi; D., Craufurd; R. E., G.; DI MARIA, Emilio; L., Arnin

    Medikamente zur Behandlung bipolarer affektiver Störungen

    No full text

    Integrative analysis of the caenorhabditis elegans genome by the modENCODE project

    No full text
    We systematically generated large-scale data sets to improve genome annotation for the nematode Caenorhabditis elegans, a key model organism. These data sets include transcriptome profiling across a developmental time course, genome-wide identification of transcription factor-binding sites, and maps of chromatin organization. From this, we created more complete and accurate gene models, including alternative splice forms and candidate noncoding RNAs. We constructed hierarchical networks of transcription factor-binding and microRNA interactions and discovered chromosomal locations bound by an unusually large number of transcription factors. Different patterns of chromatin composition and histone modification were revealed between chromosome arms and centers, with similarly prominent differences between autosomes and the X chromosome. Integrating data types, we built statistical models relating chromatin, transcription factor binding, and gene expression. Overall, our analyses ascribed putative functions to most of the conserved genome
    corecore